Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Criteria for Diagnosis of Nondiabetes, Pre-diabetes and Diabetes

Best Practice Series in Diabetes

Zachary Bloomgarden, MD, Editor of The Journal of Diabetes and Clinical Professor in the Dept. of Medicine at the Mount Sinai School of Medicine, discusses the criteria for diagnosing diabetes on the continuum of abnormal blood sugars.

Speaker’s Bureau: Merck, NovoNordisk, GSK
Advisory Panel: Merck, BMS, Astra Zeneca, Boehringer Ingelheim, Biodel
Consultant: Merck, Novartis, Dainippon Sumitomo Pharma America, Forest Laboratories
Stock/Shareholder: Covidien, Bard, Novartis, Roche, Stryker